Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 4/20 | 0.46 |
| ▸ | CTSK | P43235 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.36 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | FNTA | P49354 | 7/20 | 0.34 |
| ▸ | FNTB | P49356 | 7/20 | 0.34 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.34 |
| ▸ | CCKBR | P32239 | 2/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30590000 | 0.87 | CTSS (0.45) | CTSSCTSKCA2FNTAFNTB | |
| SCHEMBL30814919 | 0.87 | PTGS1 (0.39) | CTSSCTSKPTGS1GSTK1GLO1 | |
| SCHEMBL30480133 | 0.86 | FNTA (0.44) | CTSSCTSKPTGS1GSTK1FNTA | |
| SCHEMBL30590002 | 0.85 | PTGS1 (0.42) | CTSSCTSKPTGS1GSTK1GLO1 | |
| SCHEMBL21763976 | 0.84 | CTSS (0.47) | CTSSCTSKCA2FNTAFNTB | |
| SCHEMBL30052506 | 0.83 | TSHR (0.47) | CTSSCTSKPTGS1GSTK1GLO1 | |
| SCHEMBL30814833 | 0.82 | PTGS1 (0.38) | CTSSCTSKPTGS1GSTK1GLO1 | |
| SCHEMBL30814967 | 0.82 | PTGS1 (0.38) | CTSSCTSKPTGS1GSTK1GLO1 | |
| SCHEMBL31142113 | 0.82 | PTGS1 (0.42) | CTSSCTSKPTGS1GSTK1GLO1 | |
| SCHEMBL30575170 | 0.80 | PTGS1 (0.42) | CTSSCTSKPTGS1GSTK1GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11970551-B2 | Solution phase routes for WNT hexapeptides | WNTRESEARCH AB (SE) | 2024-04-30 | — | — | US | disclosed |
| US-11912791-B2 | Solution phase routes for Wnt hexapeptides | WNTRESEARCH AB (SE) | 2024-02-27 | — | — | US | disclosed |
| US-20230295232-A1 | SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES | WNTRESEARCH AB (SE) | 2023-09-21 | — | — | US | disclosed |